HL Genomics에이치엘지노믹스
0156T0 · KOSDAQ · ₩0156T0 · 에이치엘지노믹스
₩7,120▼ ₩30 (0.42%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −51.86%
- Market cap
- ₩55B
- Enterprise value
- ₩51B
- P/E
- —
- P/B
- 0.6×
- Dividend yield
- —
- ROE
- —
- Net margin
- —
Trailing 12 months from filed financial statements, as of H1 2026.
52-week range−72.1% from the high
₩7,000Today: ₩7,120 – ₩7,320₩25,550
Returns
- 1W−6.6%
- 1M−14.9%
- 3M−34.3%
- 6M—
- YTD−51.9%
- 1Y—
- Volume today
- 13,996
- 0.3× the 20-day average
- Traded today
- ₩101M
- Listed shares
- 7,782,161
- EPS (12 months)
- —
AI researchResearch not started yetResearch starts once this company's financial statements are available.IPOListed Jul 24, 2026 at ₩21,500IPO details →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 30 of 100 (50 is a normal day for this stock).
- MomentumWeak-14.6% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
HL Genomics stock overview
HL Genomics (에이치엘지노믹스, KRX: 0156T0) is listed on KOSDAQ, in the Biotech & Pharma sector. Its shares closed at ₩7,120 on Oct 27, 2026, down 0.42% on the day, giving it a market value of ₩55B.
Key facts
- Market cap
- ₩55B
- Sector
- Biotech & Pharma
- Latest price change
- −0.42%
- As of
- Oct 27, 2026
Quick answers about HL Genomics
- What is the market cap of HL Genomics?
- The market capitalisation of HL Genomics was ₩55B at the close on Oct 27, 2026.
- Who are the largest shareholders of HL Genomics?
- According to the latest official filings, the largest reported holders are Hanlim Pharm (66.11%, as of Jul 30, 2026).
- When is the next earnings report from HL Genomics?
- Korean companies rarely announce results dates in advance. Based on when HL Genomics filed the same report in past years, its next 2q results is expected around Aug 14, 2027.
Company profile
Loading data for this company — check back soon
- Korean name
- 에이치엘지노믹스
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 김호진
- Founded
- Nov 2000
- Listed
- Jul 2026
- Listed shares
- 7,782,161
- Fiscal year ends
- Month 12
- Website
- hlgenomics.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Determination of Shareholder Register Closure Period or Record DateOct 12, 2026
- Shareholders' meeting calledOct 12, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- New Facility Investment, etc.Aug 12, 2026
- Insider shareholding reportJul 30, 2026
Titles in Korean until English translations are added.
Also known as: HL Genomics / 에이치엘지노믹스 / 0156T0 / KRX:0156T0
Source: KRX statistical information